BioStem Technologies, Inc. BSEM
—
4.14
0.26
6.70%
as of 25 Sep
- Market cap
- $69.2M
- P/E
- 0.0×
Follow BSEM
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
| 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Debt/Assets |
0.00% | 0.00% | 0.00% |
Asset Turnover |
— | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 |
Average Assets |
— | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates